1. Home
  2. SNCR vs LXEO Comparison

SNCR vs LXEO Comparison

Compare SNCR & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • LXEO
  • Stock Information
  • Founded
  • SNCR 2000
  • LXEO 2017
  • Country
  • SNCR United States
  • LXEO United States
  • Employees
  • SNCR N/A
  • LXEO N/A
  • Industry
  • SNCR EDP Services
  • LXEO
  • Sector
  • SNCR Technology
  • LXEO
  • Exchange
  • SNCR Nasdaq
  • LXEO Nasdaq
  • Market Cap
  • SNCR 87.5M
  • LXEO 93.9M
  • IPO Year
  • SNCR 2006
  • LXEO 2023
  • Fundamental
  • Price
  • SNCR $7.30
  • LXEO $4.36
  • Analyst Decision
  • SNCR Strong Buy
  • LXEO Strong Buy
  • Analyst Count
  • SNCR 1
  • LXEO 5
  • Target Price
  • SNCR $13.00
  • LXEO $16.60
  • AVG Volume (30 Days)
  • SNCR 145.6K
  • LXEO 468.4K
  • Earning Date
  • SNCR 08-05-2025
  • LXEO 08-11-2025
  • Dividend Yield
  • SNCR N/A
  • LXEO N/A
  • EPS Growth
  • SNCR N/A
  • LXEO N/A
  • EPS
  • SNCR N/A
  • LXEO N/A
  • Revenue
  • SNCR $172,842,000.00
  • LXEO N/A
  • Revenue This Year
  • SNCR $2.07
  • LXEO N/A
  • Revenue Next Year
  • SNCR $5.42
  • LXEO N/A
  • P/E Ratio
  • SNCR N/A
  • LXEO N/A
  • Revenue Growth
  • SNCR 4.64
  • LXEO N/A
  • 52 Week Low
  • SNCR $6.00
  • LXEO $1.45
  • 52 Week High
  • SNCR $15.46
  • LXEO $13.63
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 54.11
  • LXEO 53.98
  • Support Level
  • SNCR $7.03
  • LXEO $4.07
  • Resistance Level
  • SNCR $7.67
  • LXEO $4.38
  • Average True Range (ATR)
  • SNCR 0.44
  • LXEO 0.29
  • MACD
  • SNCR 0.05
  • LXEO -0.05
  • Stochastic Oscillator
  • SNCR 62.79
  • LXEO 39.36

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: